EUVIMEDObjevte EUVIMED
Crossref

M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination

Ping Yin, Min Tang, Guosheng Zhao iD

Molecular Carcinogenesis · 2024-11 · 63 (11) · 2103-2118

DOI: 10.1002/mc.23796 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2024-07-23. Written by Ping Yin and 2 co-authors. Institution: Department of Blood Transfusion, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China. Major MEDLINE topics: Ferroptosis, Osteosarcoma, Ubiquitination, Macrophages. Cited 21 times so far (Crossref); 50 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Osteosarcoma (OS) is the most common primary malignant tumor of bone. The aim of this study was to investigate the regulatory mechanisms of M2 macrophage exosomes (M2‐Exos) in ferroptosis in OS. A mouse model was established to investigate the in vivo role of M2‐Exos. We investigated their effects on ferroptosis in OS using erastin, a ferroptosis activator, and deferoxamine mesylate, an iron chelator. In vitro, we investigated whether the Apoc1/Acyl‐CoA Synthetase Family Member 2 (ACSF2) axis mediates these effects, using shApoc1 and shACSF2. The mechanisms whereby Apoc1 regulates ACSF2 were examined using cyclohexanone, a protein synthesis inhibitor, and MG132, a proteasomal inhibitor. M2‐Exos reversed the inhibitory effects of erastin on OS cells, thus enhancing their viability, migration, invasion, proliferation, and reducing ferroptosis. Apoc1 was highly expressed in M2‐Exos, and interfering with this expression reversed the effects of M2‐Exos on OS cells. ACSF2 mediated the effects of M2‐Exos‐derived Apoc1. Apoc1 interacted with ACSF2, which, in turn, interacted with USP40. Apoc1 overexpression increased ACSF2 ubiquitination, promoting its degradation, whereas USP40 overexpression inhibited ACSF2 ubiquitination and promoted its expression. Apoc1 overexpression inhibited ACSF2 binding to USP40. M2‐Exos‐derived Apoc1 promoted ferroptosis resistance by inhibiting USP40 binding to ACSF2 and promoting ACSF2 ubiquitination and degradation, thus enhancing OS development.

Subjects

MeSH terms (MEDLINE)

FerroptosisOsteosarcomaUbiquitinationMacrophagesExosomesAnimalsMiceHumansApolipoprotein C-ICoenzyme A LigasesCell Line, TumorBone NeoplasmsCell ProliferationGene Expression Regulation, Neoplastic

Author keywords

ACSF2Apoc1M2 macrophage exosomeferroptosisosteosarcoma (OS)ubiquitination

Substances

Apolipoprotein C-ICoenzyme A Ligases

Authors and institutions

  • Department of Blood Transfusion, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Department of Blood Supply, Changsha Blood Center, Changsha, Hunan, China.

ORCID profiles: Guosheng Zhao

Cite

APA

Yin, P., Tang, M., & Zhao, G. (2024). M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination. Molecular Carcinogenesis, 63(11), 2103-2118. https://doi.org/10.1002/mc.23796

Vancouver

Yin P, Tang M, Zhao G. M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination. Molecular Carcinogenesis. 2024;63(11):2103-2118. doi:10.1002/mc.23796

BibTeX
@article{Yin2024,
  author = {Yin, Ping and Tang, Min and Zhao, Guosheng},
  title = {M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {11},
  pages = {2103--2118},
  doi = {10.1002/mc.23796}
}
Start for free →